ResMed Total Assets 2006-2019 | RMD

ResMed total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • ResMed total assets for the quarter ending September 30, 2019 were $4.155B, a 35.44% increase year-over-year.
  • ResMed total assets for 2019 were $4.108B, a 34.07% increase from 2018.
  • ResMed total assets for 2018 were $3.064B, a 11.66% decline from 2017.
  • ResMed total assets for 2017 were $3.468B, a 6.5% increase from 2016.
ResMed Annual Total Assets
(Millions of US $)
2019 $4,108
2018 $3,064
2017 $3,468
2016 $3,257
2015 $2,182
2014 $2,361
2013 $2,211
2012 $2,138
2011 $2,069
2010 $1,626
2009 $1,508
2008 $1,406
2007 $1,252
2006 $1,013
2005 $774
ResMed Quarterly Total Assets
(Millions of US $)
Q1 2019 $4,155
Q4 2019 $4,108
Q3 2019 $4,099
Q2 2018 $3,860
Q1 2018 $3,068
Q4 2018 $3,064
Q3 2018 $3,534
Q2 2017 $3,564
Q1 2017 $3,490
Q4 2017 $3,468
Q3 2017 $3,423
Q2 2016 $3,323
Q1 2016 $3,322
Q4 2016 $3,257
Q3 2016 $2,445
Q2 2015 $2,239
Q1 2015 $2,255
Q4 2015 $2,182
Q3 2015 $2,278
Q2 2014 $2,327
Q1 2014 $2,309
Q4 2014 $2,361
Q3 2014 $2,365
Q2 2013 $2,346
Q1 2013 $2,335
Q4 2013 $2,211
Q3 2013 $2,375
Q2 2012 $2,330
Q1 2012 $2,245
Q4 2012 $2,138
Q3 2012 $2,129
Q2 2011 $2,041
Q1 2011 $1,935
Q4 2011 $2,069
Q3 2011 $1,962
Q2 2010 $1,884
Q1 2010 $1,792
Q4 2010 $1,626
Q3 2010 $1,713
Q2 2009 $1,621
Q1 2009 $1,620
Q4 2009 $1,508
Q3 2009 $1,326
Q2 2008 $1,307
Q1 2008 $1,293
Q4 2008 $1,406
Q3 2008 $1,366
Q2 2007 $1,319
Q1 2007 $1,288
Q4 2007 $1,252
Q3 2007 $1,192
Q2 2006 $1,132
Q1 2006 $1,031
Q4 2006 $1,013
Q3 2006 $899
Q2 2005 $860
Q1 2005 $816
Q4 2005 $774
Q3 2005 $674
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.349B $2.607B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $159.868B 27.90
Medtronic (MDT) Ireland $159.853B 22.08
Stryker (SYK) United States $80.144B 26.95
Boston Scientific (BSX) United States $60.227B 28.43
Baxter (BAX) United States $46.348B 28.10
Essilor Luxottica (ESLOY) France $32.970B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.400B 19.07
Lonza Group Ag (LZAGY) Switzerland $30.070B 0.00
Coloplast (CLPBY) Denmark $27.194B 41.97
Terumo (TRUMY) Japan $27.183B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $22.117B 0.00
Sunny Optical Technology (SNPTF) China $19.732B 0.00
Insulet (PODD) United States $11.904B 566.35
Bio-Rad Laboratories (BIO) United States $11.075B 53.16
Perrigo (PRGO) Ireland $7.998B 14.91
Canopy Growth (CGC) Canada $7.913B 0.00
William Demant Holdings (WILYY) Denmark $7.896B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
Hill-Rom Holdings (HRC) United States $7.341B 21.13
GN STORE NORD (GNNDY) Denmark $6.158B 0.00
Haemonetics (HAE) United States $5.446B 36.80
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.013B 31.60
ICU Medical (ICUI) United States $3.880B 25.30
Neogen (NEOG) United States $3.553B 59.13
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Quidel (QDEL) United States $3.250B 30.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.132B 0.00
Agios Pharmaceuticals (AGIO) United States $3.123B 0.00
National Vision Holdings (EYE) United States $2.908B 65.64
Aurora Cannabis (ACB) Canada $2.168B 0.00
Cardiovascular Systems (CSII) United States $1.807B 0.00
InMode (INMD) Israel $1.563B 0.00
AtriCure (ATRC) United States $1.486B 0.00
TG Therapeutics (TGTX) United States $1.344B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.175B 23.49
Phibro Animal Health (PAHC) United States $1.024B 19.17
NanoString Technologies (NSTG) United States $1.005B 0.00
PetIQ (PETQ) United States $0.873B 21.30
Eagle Pharmaceuticals (EGRX) United States $0.778B 29.81
Quanterix (QTRX) United States $0.752B 0.00
LeMaitre Vascular (LMAT) United States $0.729B 40.99
Lantheus Holdings (LNTH) United States $0.708B 17.68
Omeros (OMER) United States $0.674B 0.00
Cerus (CERS) United States $0.641B 0.00
Surmodics (SRDX) United States $0.548B 56.80
MacroGenics (MGNX) United States $0.529B 0.00
OraSure Technologies (OSUR) United States $0.490B 29.41
Organigram Holdings (OGI) Canada $0.451B 0.00
Meridian Bioscience (VIVO) United States $0.408B 14.02
HEXO (HEXO) $0.401B 0.00
Owens & Minor (OMI) United States $0.394B 14.58
Utah Medical Products (UTMD) United States $0.385B 27.90
Zynex (ZYXI) United States $0.331B 37.48
BioLife Solutions (BLFS) United States $0.310B 126.17
Bovie Medical (APYX) United States $0.274B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Female Health (VERU) United States $0.243B 0.00
Vapotherm (VAPO) United States $0.241B 0.00
Repro-Med Systems (KRMD) United States $0.233B 0.00
United Health Products (UEEC) United States $0.224B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Rockwell Medical (RMTI) United States $0.164B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.132B 9.32
Chimerix (CMRX) United States $0.117B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.086B 0.00
United-Guardian (UG) United States $0.083B 20.95
MRI Interventions (MRIC) United States $0.078B 0.00
Nephros (NEPH) United States $0.077B 0.00
Chembio Diagnostics (CEMI) United States $0.074B 0.00
FSD PHARMA INC (HUGE) $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00